Your browser doesn't support javascript.
loading
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9-14 years versus an established quadrivalent HPV vaccine in women aged 15-26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial.
Sharma, Hitt; Parekh, Sameer; Pujari, Pramod; Shewale, Sunil; Desai, Shivani; Bhatla, Neerja; Joshi, Smita; Pimple, Sharmila; Kawade, Anand; Balasubramani, Latha; Thomas, Anitha; Suri, Vanita; Lalwani, Sanjay; Uday, Rajini; Kamath, Veena; Mandal, Ranajit; Rajeswar, A; Peedicayil, Abraham; Poli, Usha Rani; Banerjee, Dipanwita; Sankaranarayanan, Rengaswamy; Basu, Partha; Muwonge, Richard; Gairola, Sunil; Dogar, Vikas; Rao, Harish; Shaligram, Umesh.
Afiliação
  • Sharma H; Serum Institute of India, Pune, India. Electronic address: drhjs@seruminstitute.com.
  • Parekh S; Serum Institute of India, Pune, India.
  • Pujari P; Serum Institute of India, Pune, India.
  • Shewale S; Serum Institute of India, Pune, India.
  • Desai S; Serum Institute of India, Pune, India.
  • Bhatla N; All India Institute of Medical Sciences, New Delhi, India.
  • Joshi S; Ruby Hall Clinic, Pune, India.
  • Pimple S; Tata Memorial Hospital & Cancer Research Institute, Mumbai, India.
  • Kawade A; KEM Hospital & Research Centre, Pune, India.
  • Balasubramani L; G Kuppuswamy Naidu Memorial Hospital, Coimbatore, India.
  • Thomas A; Christian Medical College, Vellore, India.
  • Suri V; Postgraduate Institute of Medical Education & Research, Chandigarh, India.
  • Lalwani S; Bharati Vidyapeeth Medical College & Hospital, Pune, India.
  • Uday R; M S Ramaiah Medical College & Hospital, Bangalore, India.
  • Kamath V; Kasturba Medical College and TMA Pai Hospital, Manipal, India.
  • Mandal R; Chittaranjan National Cancer Institute, Kolkata, India.
  • Rajeswar A; MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad, India.
  • Peedicayil A; Christian Medical College, Vellore, India.
  • Poli UR; MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad, India.
  • Banerjee D; Chittaranjan National Cancer Institute, Kolkata, India.
  • Sankaranarayanan R; Karkinos Healthcare, Mumbai, India.
  • Basu P; International Agency for Research on Cancer, World Health Organization, Early Detection, Prevention and Infections Branch, Lyon, France.
  • Muwonge R; International Agency for Research on Cancer, World Health Organization, Early Detection, Prevention and Infections Branch, Lyon, France.
  • Gairola S; Serum Institute of India, Pune, India.
  • Dogar V; Serum Institute of India, Pune, India.
  • Rao H; Serum Institute of India, Pune, India.
  • Shaligram U; Serum Institute of India, Pune, India.
Lancet Oncol ; 24(12): 1321-1333, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37949086
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus Limite: Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Papillomavirus / Vacinas contra Papillomavirus Limite: Female / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article